Small caps raced ahead Monday, while the major blue-chip indexes produced more mixed results, as investors continued to digest last week's jobs report and several other moving macroeconomic parts.
President Joe Biden on Friday rejected the GOP's most recent infrastructure package but was set to meet today with Republican Sen. Shelley Moore Capito, of West Virginia, to continue negotiations.
Also of note were comments from Treasury Secretary Janet Yellen, who said Biden's spending plans could lead to higher interest rates – but that such a result "would actually be a plus for society's point of view and the Fed's point of view," adding that both rates and inflation have been too low over the past decade.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Don't expect higher rates anytime soon, however; BlackRock Investment Institute strategists say the Federal Reserve "faces a very high bar to change its easy monetary policy stance."
The Dow Jones Industrial Average (-0.4% to 34,630) and S&P 500 (off marginally to 4,226) both declined modestly, while the Nasdaq Composite managed a 0.5% gain to 13,881. The tech-heavy index was helped by a massive 38.3% surge in Biogen (BIIB) shares, which came alive after the Food and Drug Administration approved the company's Alzheimer's treatment.
"We had upgraded BIIB on the potential for the regulatory saga around adu to create significant upside," says Canaccord Genuity analyst Sumant Kulkarni (Buy). "Some might take profits here, but we continue to like the stock as today's approval allows BIIB to play much more strategic offense vs. what was a largely defensive posture earlier forced by competition to core products such as Tecfidera, Spinraza, etc."
Other action in the stock market today:
- Eli Lilly (LLY, +10.2%) surged to a record high today on a halo lift from BIIB. The Indianapolis-based pharmaceutical firm is developing its own drug to treat Alzheimer's disease.
- Tesla (TSLA, +1.0%) has ended plans to produce the Plaid+ sedan – the priciest version of its Model S series. CEO Elon Musk broke the news via Twitter on Sunday, tweeting "Plaid+ is canceled. No need, as Plaid is just so good."
- U.S. crude oil futures slipped 0.6% to end at $69.23 per barrel.
- Gold futures gave back 0.4% to settle at $1,898.80 an ounce.
- The CBOE Volatility Index (VIX) edged 0.1% higher to 16.44.
- Bitcoin prices declined 3.3% from Friday to $35,679.55. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m. each trading day.)
Small-Cap Stocks Come Out on Top
As a group, small-cap stocks were Monday's biggest winner. The Russell 2000 gained 1.4% to 2,319, putting it within 2.0% of its March 15 closing high of 2,360.
"The Reddit favorites are back in vogue again today," says Michael Reinking, senior market strategist for the New York Stock Exchange, referring to so-called meme stocks such as AMC Entertainment (AMC, +14.8%) and GameStop (GME, +12.7%).
But they weren't alone. Cloud computing, electric vehicles and online gambling were among Monday's more exciting pockets of strength.
More broadly, it was a productive day for "innovative growth stocks" – companies that are somehow breaking the mold in their respective industries. Analysts are particularly high on these 15 firms' long-term prospects, lauding not just their breakthrough technologies, but also adept management concerned with sustainable cash flows and returning capital to shareholders. Take a look at 15 innovators that stand out.
-
The $33,000 Retirement: One Man's Surprising Path to Financial Freedom at 61Forget what society tells you, even with less than $1 million, you can be happy in retirement.
-
The Best Aerospace and Defense ETFs to BuyThe best aerospace and defense ETFs can help investors capitalize on higher government defense spending or hedge against the potential of a large-scale conflict.
-
Stock Market Today: Another Quarter, More Mixed Price Action"Up and to the right" remains the general trend despite persistent uncertainty around critical policy issues.
-
The Riskiest S&P 500 Stocks Right NowBuyer beware: These are five of the riskiest stocks in the S&P 500 at the moment, based on one measure of volatility.
-
Stock Market Today: Stocks Chop as Chipmakers DeclineSeveral semiconductor stocks fell Friday on reports that the White House may consider revising license waivers for global chipmakers.
-
Stock Market Today: Wall Street Is Standing ByThe waiting is the hardest part with trade war truce talks underway and inflation data on the way.
-
Stock Market Today: Stocks Stable as Inflation, Tariff Fears EbbConstructive trade war talks and improving consumer expectations are a healthy combination for financial markets.
-
Stock Market Today: Good Feelings and Solid Data Lift StocksResilience and de-escalation defined another generally positive day for financial markets.
-
Stock Market Today: Tesla Drags on Stocks Amid Musk-Trump FeudSentiment has soured between President Trump and his once-loyal ally, Tesla CEO Elon Musk.
-
Stock Market Today: Rally Extends on Good-Enough ExpectationsFiscal policy still has markets' attention, but taxes rather than tariffs and deficits rather than inflation are participants' primary focus.
